Virulence, immunity, and vaccine related to Streptococcus pneumoniae - PubMed (original) (raw)
Review
Virulence, immunity, and vaccine related to Streptococcus pneumoniae
C J Lee et al. Crit Rev Microbiol. 1991.
Abstract
The pathogenesis of bacterial infection involves a series of interactions between the virulence determinants of the microorganisms and the immunity of the host. Studies on the molecular structure and immunological properties of pneumococcal virulence factors have provided general knowledge for the chemical basis of immunogenicity and prevention of bacterial infection. Antibody responses to PS and protein antigens can be greatly affected by their physicochemical properties, e.g., molecular size, specific determinants, conformation, etc. Characterization of group 19 pneumolysins and cloning of their ply genes were studied to examine the relationship of ply to virulence. Group 19 pneumococci all contained ply; the disease-isolated types of 19F and 19A appeared to show a higher specific hemolytic activity and yield than the nonpathogenic types, 19B and 19C. Genomic DNA that contained the ply gene from group 19 strains were analyzed by the polymerase chain reaction (PCR). Type 2 oligonucleotide primers recognized and initiated synthesis of an identical 1.5 kb DNA fragment in types 2, 19F, 19A, 19B, and 19C. Their sizes of restriction DNA fragments were also found to be homologous. Thus, group 19 ply genes showed remarkably similar characteristics. A difficult problem in the development of vaccines against bacterial diseases is the poor immune response of young children to purified PSs. The efficacy of pneumococcal vaccine might be improved by supplementation with inactivated pneumolysin in the form of a PS-protein conjugate.
Similar articles
- Immunologic epitope, gene, and immunity involved in pneumococcal glycoconjugate.
Lee CJ, Wang TR, Tai SS. Lee CJ, et al. Crit Rev Microbiol. 1997;23(2):121-42. doi: 10.3109/10408419709115133. Crit Rev Microbiol. 1997. PMID: 9226111 Review. - Protective immunity and gene expression related to pneumococcal glycoconjugate.
Lee CJ, Li ZM. Lee CJ, et al. Adv Exp Med Biol. 2001;491:505-14. doi: 10.1007/978-1-4615-1267-7_33. Adv Exp Med Biol. 2001. PMID: 14533818 - Bacterial capsular polysaccharides--biochemistry, immunity and vaccine.
Lee CJ. Lee CJ. Mol Immunol. 1987 Oct;24(10):1005-19. doi: 10.1016/0161-5890(87)90067-8. Mol Immunol. 1987. PMID: 3119993 Review. - Pneumococcal infection and immunization in children.
Lee CJ, Wang TR. Lee CJ, et al. Crit Rev Microbiol. 1994;20(1):1-12. doi: 10.3109/10408419409113544. Crit Rev Microbiol. 1994. PMID: 8185832 Review. - Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin.
Lock RA, Zhang QY, Berry AM, Paton JC. Lock RA, et al. Microb Pathog. 1996 Aug;21(2):71-83. doi: 10.1006/mpat.1996.0044. Microb Pathog. 1996. PMID: 8844651
Cited by
- Facile synthesis of nitrophenyl 2-acetamido-2-deoxy-α-D-mannopyranosides from ManNAc-oxazoline.
Křenek K, Simon P, Weignerová L, Fliedrová B, Kuzma M, Křen V. Křenek K, et al. Beilstein J Org Chem. 2012;8:428-32. doi: 10.3762/bjoc.8.48. Epub 2012 Mar 20. Beilstein J Org Chem. 2012. PMID: 22509213 Free PMC article. - T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.
Szomolanyi-Tsuda E, Seedhom MO, Carroll MC, Garcea RL. Szomolanyi-Tsuda E, et al. Virology. 2006 Aug 15;352(1):52-60. doi: 10.1016/j.virol.2006.04.018. Epub 2006 Jun 2. Virology. 2006. PMID: 16733062 Free PMC article. - Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children.
Brüssow H, Baensch M, Sidoti J. Brüssow H, et al. J Clin Microbiol. 1992 Nov;30(11):2765-71. doi: 10.1128/jcm.30.11.2765-2771.1992. J Clin Microbiol. 1992. PMID: 1452644 Free PMC article. - Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.
Briles DE, Forman C, Crain M. Briles DE, et al. Infect Immun. 1992 May;60(5):1957-62. doi: 10.1128/iai.60.5.1957-1962.1992. Infect Immun. 1992. PMID: 1563788 Free PMC article. - Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.
Alexander JE, Lock RA, Peeters CC, Poolman JT, Andrew PW, Mitchell TJ, Hansman D, Paton JC. Alexander JE, et al. Infect Immun. 1994 Dec;62(12):5683-8. doi: 10.1128/iai.62.12.5683-5688.1994. Infect Immun. 1994. PMID: 7960154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources